IP Library › Granted Patent US 9,676,808
Granted Patent B2
US 9,676,808 · App. 15/007,810 · Granted Jun 13, 2017

2′,4′-substituted nucleosides as antiviral agents

Inventors: Jinfa Du (Redwood City, CA); Michael Joseph Sofia (Doylestown, PA)
Assignee: GILEAD PHARMASSET LLC
C07H19/06A61K31/7064A61K31/7068A61K31/7072A61K31/7076C07H19/073C07H19/14C07H19/16C07H19/173
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,676,808
App. No.
15/007,810
Granted
Jun 13, 2017
Kind
B2
Abstract

Embodiments of the invention are to compounds, methods, and compositions for use in the treatment of viral infections. More specifically embodiments of the invention are 2′,4′-substituted nucleoside compounds useful for the treatment of viral infections, such as HIV, HCV, and HBV infections.

Claims (1)

1. A compound selected from

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2022
From: GILEAD PHARMASSET LLC
To: GILEAD SCIENCES, INC.
Reel/Frame 060217/0738 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR DATA PREVIOUSLY RECORDED ON REEL 038554 FRAME 0043. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 22, 2016
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 041175/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2016
From: SOFIA, MICHAEL J.; DU, JINFA
To: PHARMASSET, INC.
Reel/Frame 038411/0871 →
CHANGE OF NAME Recorded Apr 28, 2016
From: PHARMASSET LLC
To: GILEAD PHARMASSET LLC.
Reel/Frame 038554/0043 →
Continuity (5)
Continuation 14265840 · Apr 30, 2014
Continuation 13324068 · Dec 13, 2011
Continuation 12271388 · Nov 14, 2008
Provisional Application 60989296 · Nov 20, 2007
Related Publication 20160280735A1 · Sep 29, 2016